|Videos|December 28, 2018
Emerging Agents for Myelofibrosis
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Atopic Dermatitis Clinical Trial Representation: Addressing Historical Gaps
September 19th 2025
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Efficacy of Ruxolitinib Cream in Nonsegmental Vitiligo Confirmed in Real-World Study
2
Iron Dysregulation Linked to MS Progression, Review Finds
3
Metabolic Issues More Common in Patients With HIV
4
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
5